Tesamorelin
Egrifta
Mechanism
GHRH-Analogon, das speziell auf das viszerale Fettgewebe (VAT) abzielt und die Freisetzung von Wachstumshormonen stimuliert.
Half-Life
30-40 minutes
Administration
Technical Protocol
Tesamorelin Guide
Tesamorelin is FDA-approved for the treatment of HIV-associated lipodystrophy.
Peer-Reviewed Citations
Tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with abdominal fat accumulation
Falutz J, et al. • N Engl J Med (2007)
Access ResearchFrequently Asked Questions
What is Tesamorelin?
Das wirksamste GHRH-Analogon zur Reduzierung des viszeralen Fetts.
How does Tesamorelin work?
GHRH-Analogon, das speziell auf das viszerale Fettgewebe (VAT) abzielt und die Freisetzung von Wachstumshormonen stimuliert.
What is the typical dosage of Tesamorelin in research?
The typical research dosage of Tesamorelin is 2 mg (range: 1-2 mg daily). Common administration routes include Subcutaneous.
How should Tesamorelin be stored?
Store at 2-8°C, protect from light
Source Tesamorelin for Your Research
Third-party tested, EU-shipped, certificate of analysis included. High-purity Tesamorelin available from our verified research partner.
Shop TesamorelinRelated Hormonal Peptides
Ipamorelin
A potent and selective growth hormone secretagogue that stimulates growth hormone release.
hormonalCJC-1295 (No DAC)
A modified version of GHRH 1-29, designed to stimulate growth hormone release.
hormonalKisspeptin-10
A key regulator of the reproductive axis.
hormonalOxytocin
The hormone of social connection and maternal bonding.